• 1
    Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch. Gen. Psychiatry 1993; 50: 565576.
  • 2
    Loeber R, Dishion T. Early predictors of male delinquency: A review. Psychol. Bull. 1983; 94: 6899.
  • 3
    Lilienfeld SO, Waldman ID. The relation between childhood attention-deficit hyperactivity disorder and adult antisocial behavior behavior reexamined: the problem of heterogeneity. Clin. Psychol. Rev. 1990; 10: 699725.
  • 4
    Gittelman R, Mannuzza S, Shenker R, Bonagura N. Hyperactive boys almost grown up. I. Psychiatric status. Arch. Gen. Psychiatry 1985; 42: 937947.
  • 5
    Woodward L, Taylor E, Dowdney L. The parenting and family functioning of children with hyperactivity. J. Child Psychol. Psychiatry 1998; 39: 161169.
  • 6
    Smalley SL. Genetic influences in childhood-onset psychiatric disorders: Autism and attention-deficit/hyperactivity disorder. Am. J. Hum. Genet. 1997; 60: 12761282.
  • 7
    Waldman ID, Rowe DC, Abramowitz A et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet. 1998; 63: 17671776.
  • 8
    Thapar A, Holmes J, Poulton K, Harrington R. Genetic basis of attention deficit and hyperactivity. Br. J. Psychiatry 1999; 174: 105111.
  • 9
    Bobb AJ, Castellanos FX, Addington AM, Rapoport JL. Molecular genetic studies of ADHD: 1991 to 2004. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 132: 109125.
  • 10
    Chen CK, Chen SL, Mill J et al. The dopsmine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample. Mol. Psychiatry 2003; 8: 393396.
  • 11
    Brookes KJ, Mill J, Guindalini C et al. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch. Gen. Psychiatry 2006; 63: 7481.
  • 12
    Asherson P, Kuntsi J, Taylor E. Unravelling the complexity of attention-deficit hyperactivity disorder: A behavioural genomic approach. Br. J. Psychiatry 2005; 187: 103105.
  • 13
    Amara SG, Kuhar MJ. Neurotransmitter transporters: Recent progress. Annu. Rev. Neurosci. 1993; 16: 7393.
  • 14
    Zarin DA, Suarez AP, Pincus HA, Kupersanin E, Zito JM. Clinical and treatment characteristics of children with attention-deficit/hyperactivity disorder in psychiatric practice. J. Am. Acad. Child Adolesc. Psychiatry 1998; 37: 12621270.
  • 15
    Overtoom CC, Verbaten MN, Kemner C et al. Effects of methylphenidate, desipramine, and 1-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder. Behav. Brain Res. 2003; 145: 715.
  • 16
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washinton DC, 1994.
  • 17
    Greenberg LM, Waldman ID. Developmental normative data on the test of variables of attention (T.O.V.A.). J. Child Psychol. Psychiatry 1993; 34: 10191030.
  • 18
    Losier BJ, McGrath PJ, Klein RM. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J. Child Psychol. Psychiatry 1996; 37: 971987.
  • 19
    Forbes GB. Clinical utility of the Test of Variables of Attention (TOVA) in the diagnosis of attention-deficit/hyperactivity disorder. J. Clin. Psychol 1998; 54: 461476.
  • 20
    Wada N, Yamashita Y, Matsuishi T, Ohtani Y, Kato H. The test of variables of attention (TOVA) is useful in the diagnosis of Japanese male children with attention deficit hyperactivity disorder. Brain Dev. 2000; 22: 378382.
  • 21
    Gau SF, Soong WT. Psychiatric comorbidity of adolescents with sleep terrors or sleep walking: A case-control study. Austral. N. Zeal. J. Psychiatry 1999; 33: 734739.
  • 22
    Puig-Antich J, Orraschel H. Schedule for Affective Disorders and Schizophrenia for School-age Children. Epidemiologic Version and Present Episode Version. Western Psychiatric Institute and Clinic, Pittsburgh, 1990.
  • 23
    Wechsler D. Manual for the Wechsler Intelligence Scale for Children, 3rd edn (Chinese Version). The Psychological Corporation, San Antonio, 1991.
  • 24
    Greenberg LM. Test of Variables of Attention. University Attention Disorder Inc., Los Alamitos, 1996.
  • 25
    Klorman R, Salzman LF, Pass HL, Borgstedt AD, Dainer KB. Effects of methylphenidate on hyperactive children's evoked responses during passive and active attention. Psychophysiology 1979; 16: 2329.
  • 26
    Greenberg LM. An objective measure of methylphenidate response: Clinical use of the MCA. Psychopharmacol. Bull. 1987; 23: 279282.
  • 27
    Hastings JE, Barkley RA. A review of psychophysiological research with hyperkinetic children. J. Abnorm. Child Psychol. 1978; 6: 413447.
  • 28
    Aggarwal A, Lillystone D. A follow-up pilot study of objective measures in children with attention deficit hyperactivity disorder. J. Paediatr. Child Health 2000; 36: 134138.
  • 29
    Konrad K, Gunther T, Hanisch C, Herpertz-Dahlmann B. Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 2004; 43: 191198.
  • 30
    Michael RL, Klorman R, Salzman LF, Borgstedt AD, Dainer KB. Normalizing effects of methylphenidate on hyperactive children's vigilance performance and evoked potentials. Psychophysiology 1981; 18: 665677.
  • 31
    Coons HW, Peloquin LJ, Klorman R et al. Effect of methylphenidate on young adult's vigilance and event-related potentials. Electroencephalogr. Clin. Neurophysiol. 1981; 51: 373387.
  • 32
    Fitzpatrick P, Klorman R, Brumaghim JT, Keefover RW. Effects of methylphenidate on stimulus evaluation and response processes: Evidence from performance and event-related potentials. Psychophysiology 1988; 25: 292304.
  • 33
    De Sonneville LM, Njiokiktjien C, Hilhorst RC. Methylphenidate-induced changes in ADDH information processors. J. Child Psychol. Psychiatry 1991; 32: 285295.
  • 34
    Barkley RA. Behavioral inhibition, sustained attention, and executive functions. constructing a unifying theory of ADHD. Psychol. Bull. 1997; 121: 6594.
  • 35
    Solanto MV. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav. Brain Res. 2002; 130: 6571.
  • 36
    Van Der Meere J, Gunning B, Stemerdink N. The effect of methylphenidate and clonidine on response inhibition and state regulation in children with ADHD. J. Child Psychol. Psychiatry 1999; 40: 291298.